☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Eli Lilly
Eli Lilly Reports the P-III (SURMOUNT-OSA) Study Data of Tirzepatide in Patients with Obstructive Sleep Apnea (OSA) and Obesity
April 18, 2024
Eli Lilly and Boehringer Ingelheim Report the P-III (EMPACT-MI) Study Data of Jardiance on Risk of Heart Failure and Death Followi...
April 8, 2024
Eli Lilly Highlights Results from the P-III Study of Lebrikizumab for People with Skin of Color and Moderate-to-Severe Atopic Derm...
March 11, 2024
Top 20 Biopharma M&A of 2023 by Total Deal Value
January 24, 2024
Eli Lilly Highlights Results from the P-I/II (AK-OTOF-101) Study of AK-OTOF for Genetic Hearing Loss
January 24, 2024
Insights+: The US FDA New Drug Approvals in December 2023
January 17, 2024
Load more...
Back to Home